During the past decade, Health Partners Inc conducted 179 clinical trials. In the 10-year time frame, 179 clinical trials started and 74 clinical trials were completed, i.e. on average, 41.3% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 64 clinical trials were completed. i.e. 86.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Health Partners Inc" #1 sponsor was "National Cancer Institute (NCI)" with 97 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "Alliance for Clinical Trials in Oncology" with 34 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Health Partners Inc" #1 collaborator was "National Cancer Institute (NCI)" with 120 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Health Partners Inc" are "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Recurrent Ovarian Carcinoma" (7 trials). Many other conditions were trialed in "Health Partners Inc" in a lesser frequency.

Most popular intervention types in "Health Partners Inc" are "Drug" (165 trials), "Other" (139 trials), "Biological" (85 trials), "Procedure" (61 trials) and "Radiation" (25 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (63 trials), "Quality-of-Life Assessment" (61 trials), "Questionnaire Administration" (38 trials), "Biospecimen Collection" (31 trials) and "Computed Tomography" (31 trials). Other intervention names were less common.

The vast majority of trials in "Health Partners Inc" are 184 trials for "All" genders, 34 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Health Partners Inc". undefined are not yet recruiting, 66 are recruiting, 104 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Health Partners Inc, 7 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Health Partners Inc, 3 "Phase 1" clinical trials were conducted, 109 "Phase 2" clinical trials and 102 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".